Flavonoids, Blood Pressure and Blood Vessel Function

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Cardiovascular Disease Risk Reduction
Interventions
DIETARY_SUPPLEMENT

Flavanone - supplement

acute single optimal dose

OTHER

Flavanone - food

acute single dose

OTHER

Flavanone - placebo

acute single dose (flavanone free)

DIETARY_SUPPLEMENT

Isoflavone - supplement

acute single optimal dose

OTHER

Isoflavone - food

acute single optimal dose

OTHER

Isoflavone - placebo

acute single dose (isoflavone free)

DIETARY_SUPPLEMENT

Isoflavone - metabolite supplement

acute single optimal dose of commercial product

DIETARY_SUPPLEMENT

Flavan-3-ol - supplement

acute single optimal dose

OTHER

Flavan-3-ol - food

acute single optimal dose

OTHER

Flavan-3-ol - placebo

acute single dose (flavan-3-ol free)

DIETARY_SUPPLEMENT

Anthocyanin - supplement

acute single optimal dose

OTHER

Anthocyanin - food

acute single optimal dose

OTHER

Anthocyanin - placebo

acute single dose (anthocyanin free)

Trial Locations (1)

NR4 7TJ

Department of Nutrition, Norwich Medical School, Norwich

All Listed Sponsors
lead

University of East Anglia

OTHER

NCT01530893 - Flavonoids, Blood Pressure and Blood Vessel Function | Biotech Hunter | Biotech Hunter